|
Market Cap (1-Jul) $349,341,600 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 31 March 2023, 17:47. The announcement is marked as price sensitive, and is 3 page(s) in length and 283.42kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.461% short sold according to ASIC data. It was ranked the 337th most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Positive Final Data in 2nd Line Metastatic NSCLC Patients | 31 March 2023, 17:47 |
| Change in substantial holding | 31 March 2023, 8:15 |
| Expansion of INSIGHT-003 trial for Efti in 1st Line NSCLC | 30 March 2023, 9:57 |
| Abstract accepted for ESMO's European Lung Cancer Congress | 23 March 2023, 11:22 |
You must be logged in to post a reply.
